1. Could Amgen’s latest bad news boost their interest in acquisitions? — Senators urge FTC to scrutinize pharma mega-mergers — Merck’s Keytruda combo wins simultaneous approvals in US, Canada, and Australia — See more on our front page news

    TRY TWO WEEKS OF OUR EMAIL NEWS HEADLINES FOR FREE
    Dismiss Notice
  2. Think you have witnessed fraud?Ask a Whistleblower Attorney -- a chance to discuss whistleblower-related legal issues with practicing whistleblower attorneys.
    Dismiss Notice

Idev Technologies

Anonymous message board for Idev Technologies